Zeshaan Rasheed, Senior Vice President, Head of Oncology Clinical Development at GSK, made the following post on LinkedIn:
At GSK, we know that the best science doesn’t happen in isolation. Effective business development is powered by strong, cross-functional collaboration. Our approach brings together expertise across R&D, Regulatory, Safety, Medical and Global Product Strategy teams. This integrated effort is crucial as we identify and review opportunities to bolster our oncology portfolio and accelerate the development of innovative treatments.
The landscape of innovation is truly worldwide. We are seeing opportunities for business development deals globally, particularly for cutting-edge mechanisms of action and discovery-stage novel targets. With GSK Business Development teams located across the globe, we’re well-positioned to tap into this worldwide innovation.
I look forward to forging new collaborations that will help us get ahead of cancer together.
Zeshaan Rasheed/LinkedIn
More insights from brilliant minds across oncology on OncoDaily.